Skip to main content

Table 1 Characteristics of participants who received medications for opioid use disorder while incarcerated in Massachusetts jails, 2022 (n = 38)

From: Perceptions of extended-release buprenorphine among people who received medication for opioid use disorder in jail: a qualitative study

Characteristic

Count (%)

Age, mean (SD)

41.5 (9.3) Missing = 1

Female, n (%)

4 (14.3)

Race, n (%)

 

 White

32 (84.2)

 Black or African American

3 (7.9)

 Native Hawaiian or Other Pacific Islander

1 (2.6)

 More than one race

2 (5.3)

 Hispanic/Latino ethnicity, n (%)

9 (23.7)

Education, n (%)

 

 No high school diploma

8 (21.1)

 High school diploma or equivalent

19 (50.0)

 Some college, but no degree

9 (23.7)

 Associate's degree

2 (5.3)

 Not currently taking MOUD, n (%)

2 (5.3)

 Currently taking MOUD, n (%)

36 (94.7)

 Buprenorphine (e.g., Suboxone, Subutex)

20 (55.6)

 Methadone

11 (30.6)

 XR-Bup (Sublocade)

4 (11.1)

 XR-Naltrexone (Vivitrol)

1 (2.8)

County of incarceration, n (%)

 

 A

1 (2.6)

 B

6 (13.2)

 C

4 (10.5)

 D

8 (21.1)

 E

3 (7.9)

 F

6 (15.8)

 G

3 (7.9)

 H

7 (18.4)